Saedi MS - Search Results

1

Expression of human glandular kallikrein, hK2, in mammalian cells.

Kumar A, Goel AS, Hill TM, Mikolajczyk SD, Millar LS, Kuus-Reichel K, Saedi MS. Kumar A, et al. Among authors: saedi ms. Cancer Res. 1996 Dec 1;56(23):5397-402. Cancer Res. 1996. PMID: 8968092

2

Overexpression of a human prostate-specific glandular kallikrein, hK2, in E. coli and generation of antibodies.

Saedi MS, Cass MM, Goel AS, Grauer L, Hogen KL, Okaneya T, Griffin BY, Klee GG, Young CY, Tindall DJ. Saedi MS, et al. Mol Cell Endocrinol. 1995 Apr 1;109(2):237-41. doi: 10.1016/0303-7207(95)03508-5. Mol Cell Endocrinol. 1995. PMID: 7664987

3

Identification of human glandular kallikrein hK2 from LNCaP cells.

Grauer LS, Charlesworth MC, Saedi MS, Finlay JA, Liu RS, Kuus-Reichel K, Young CY, Tindall DJ. Grauer LS, et al. Among authors: saedi ms. J Androl. 1996 Jul-Aug;17(4):353-9. J Androl. 1996. PMID: 8889697 Free article.

4

Ala217 is important for the catalytic function and autoactivation of prostate-specific human kallikrein 2.

Mikolajczyk SD, Millar LS, Marker KM, Grauer LS, Goel A, Cass MM, Kumar A, Saedi MS. Mikolajczyk SD, et al. Among authors: saedi ms. Eur J Biochem. 1997 Jun 1;246(2):440-6. doi: 10.1111/j.1432-1033.1997.00440.x. Eur J Biochem. 1997. PMID: 9208936 Free article.

5

Expression of pro form of prostate-specific antigen by mammalian cells and its conversion to mature, active form by human kallikrein 2.

Kumar A, Mikolajczyk SD, Goel AS, Millar LS, Saedi MS. Kumar A, et al. Among authors: saedi ms. Cancer Res. 1997 Aug 1;57(15):3111-4. Cancer Res. 1997. PMID: 9242434

6

Human glandular kallikrein, hK2, shows arginine-restricted specificity and forms complexes with plasma protease inhibitors.

Mikolajczyk SD, Millar LS, Kumar A, Saedi MS. Mikolajczyk SD, et al. Among authors: saedi ms. Prostate. 1998 Jan 1;34(1):44-50. doi: 10.1002/(sici)1097-0045(19980101)34:1<44::aid-pros6>3.0.co;2-k. Prostate. 1998. PMID: 9428387

7

The precursor form of the human kallikrein 2, a kallikrein homologous to prostate-specific antigen, is present in human sera and is increased in prostate cancer and benign prostatic hyperplasia.

Saedi MS, Hill TM, Kuus-Reichel K, Kumar A, Payne J, Mikolajczyk SD, Wolfert RL, Rittenhouse HG. Saedi MS, et al. Clin Chem. 1998 Oct;44(10):2115-9. Clin Chem. 1998. PMID: 9761243

8

Large-scale propagation of recombinant adherent cells that secrete a stable form of human glandular kallikrein, hK2.

Kumar A, Goel AS, Payne JK, Evans C, Mikolajczyk SD, Kuus-Reichel K, Saedi MS. Kumar A, et al. Among authors: saedi ms. Protein Expr Purif. 1999 Feb;15(1):62-8. doi: 10.1006/prep.1998.0998. Protein Expr Purif. 1999. PMID: 10024471

9

Prostatic human kallikrein 2 inactivates and complexes with plasminogen activator inhibitor-1.

Mikolajczyk SD, Millar LS, Kumar A, Saedi MS. Mikolajczyk SD, et al. Among authors: saedi ms. Int J Cancer. 1999 May 5;81(3):438-42. doi: 10.1002/(sici)1097-0215(19990505)81:3<438::aid-ijc18>3.0.co;2-u. Int J Cancer. 1999. PMID: 10209959

10

Different proportions of various prostate-specific antigen (PSA) and human kallikrein 2 (hK2) forms are present in noninduced and androgen-induced LNCaP cells.

Kumar A, Mikolajczyk SD, Hill TM, Millar LS, Saedi MS. Kumar A, et al. Among authors: saedi ms. Prostate. 2000 Aug 1;44(3):248-54. doi: 10.1002/1097-0045(20000801)44:3<248::aid-pros10>3.0.co;2-d. Prostate. 2000. PMID: 10906742

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters